Doshisha Co (7483) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
30 Oct, 2026Executive summary
H1 FY27 net sales rose 2.1% YoY to ¥60.216bn, while operating profit fell 8.7% to ¥5.609bn and profit attributable to owners fell 7.9% to ¥3.969bn.
Full-year FY27 guidance remains unchanged: net sales ¥129.0bn, operating profit ¥12.2bn, ordinary profit ¥12.5bn and parent-attributable profit ¥8.55bn.
Financial highlights
Gross profit was ¥18.352bn versus ¥18.042bn; SG&A rose to ¥12.742bn from ¥11.898bn.
Ordinary profit decreased 7.2% YoY to ¥5.858bn; comprehensive income fell to ¥3.785bn from ¥4.650bn.
Cash flow from operating activities was ¥2.648bn versus ¥4.448bn; cash and cash equivalents ended H1 at ¥25.364bn versus ¥35.418bn a year earlier.
Outlook and guidance
FY27 forecast: net sales ¥129.0bn (+7.0%), operating profit ¥12.2bn (+2.2%), ordinary profit ¥12.5bn (+1.1%) and parent-attributable profit ¥8.55bn (-1.1%).
FY27 forecast basic EPS is ¥238.35; earnings forecast revisions were not made.
FY27 annual dividend forecast was revised to ¥120 per share.
Latest events from Doshisha Co
- Sales and profits rose modestly, with a stable outlook and steady dividend forecast.7483
Q1 2027 - Strong profit growth and higher dividends, with sales expected to rise further next year.7483
Q4 2026 - Strong profit growth and positive outlook, with robust segment performance and stable dividends.7483
Q3 2026 - Operating profit surged 46.9% year-over-year, with robust sales and strong full-year guidance.7483
Q2 2026 - Sales rose but profits dipped; full-year outlook remains positive with higher dividends.7483
Q1 2025 - Sales rose 5.1% year-over-year, with stable profits and a higher full-year dividend forecast.7483
Q2 2025 - Sales and profits rose year-over-year, with a higher dividend forecast and strong equity position.7483
Q3 2025 - Strong sales and profit growth with positive outlook and higher dividends forecast.7483
Q4 2025 - Operating profit surged 40.3% year-over-year on 7.6% higher sales, with robust full-year guidance.7483
Q1 2026